Understanding immune responses to tuberculosis in infants exposed to HIV

Immune correlates of LTBI in HIV-exposed infants

NIH-funded research University of Miami School of Medicine · NIH-10747368

This study is looking at how latent tuberculosis infection (LTBI) impacts babies who are exposed to HIV, by checking their immune responses through blood samples from both moms and babies, to help find better ways to keep these little ones safe from tuberculosis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine NIH-funded
Lab location1 site (Coral Gables, United States)
Project IDNIH-10747368 on NIH RePORTER

What this research studies

This research investigates how latent tuberculosis infection (LTBI) affects infants who are exposed to HIV, focusing on their immune responses. By analyzing maternal and infant blood samples, the study aims to uncover the relationship between maternal health, HIV exposure, and the risk of developing active tuberculosis in infants. The research utilizes advanced techniques like flow cytometry to assess immune cell characteristics and responses. The goal is to improve understanding of how to protect these vulnerable infants from tuberculosis.

Who could benefit from this research

Good fit: Ideal candidates for this research are infants who are exposed to HIV, particularly those born to HIV-positive mothers.

Not a fit: Patients who are not exposed to HIV or who are older than infants may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better prevention strategies and vaccines for tuberculosis in infants exposed to HIV.

How similar studies have performed: Previous research has shown promise in understanding immune responses in similar populations, but this specific approach is relatively novel.

Where this research is happening

Coral Gables, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.